Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

By Perroud Herman A   Rico Maria José   Alasino Carlos M   Queralt Francisco   Mainetti Leandro E   Pezzotto Stella M   Rozados Viviana R   Scharovsky O Graciela  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 451-462

Future Medicine

Access to resources Recommend Favorite

Antiangiogenic Agents in Breast Cancer

By Salter John   Miller Kathy  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 518-526

Informa Healthcare

Access to resources Recommend Favorite

Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice

By Jiang Hongchi   Tao Weiyang   Zhang Mu   Pan Shangha   Kanwar Jagat R.   Sun Xueying  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 74-84

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic treatment approaches in breast cancer

By Bartsch Rupert   Berghoff Anna S   Preusser Matthias   Steger Guenther G   Zielinski Christoph C  

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 397-406

Future Medicine

Access to resources Recommend Favorite

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

By                

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 439-445

Spandidos Publications

Access to resources Recommend Favorite